Clinical Trial

A Study of HS-10587 in Patients With Advanced Solid Tumors

Name: A Study of HS-10587 in Patients With Advanced Solid Tumors — clinical trial record (NCT07567859)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I, multicenter, open-label clinical trial with dose escalation/dose expansion phases, designed to evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic (PK/PD) profiles, and antitumor efficacy characteristics of HS-10587 in patients with MTAP-deleted advanced solid tumors.

Trial Details

NCT Number	NCT07567859
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	MTAP Deletion
Enrollment	362 participants
Start Date	2026-06-04
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-05